TKI, Chemo Combo Potential Salvage Option in Epithelioid Sar

The combination of salvage irinotecan, vincristine, and anlotinib may be another option for refractory epithelioid sarcoma. The study was published as a preprint and has not yet been peer reviewed.

Related Keywords

China , Chinese , , Drug Administration , Sarcoma , Peer Review , Refractory , Tyrosine Kinase Inhibitor , Rlotinib , Efitinib , Matinib , U11248 , Unitinib , Chemotherapy , Epigenetics , Fellowship , Yellows , Hospitals , Metastasis , Myelosuppression , Bone Marrow Suppression , Neoadjuvant , Physician Assistants , Surgery , Tyrosine Kinase , Biologic Therapy , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Human Coronavirus ,